Results 261 to 270 of about 3,365,654 (307)

The benefits of exercise in postmenopausal women

Australian Journal of Public Health, 1993
Abstract: Physical exercise is commonly promoted as a panacea. However many of the claimed benefits, in particular any positive effects on bone density, have not been scientifically proved. We assessed the effects of a twice‐weekly aerobic weight‐bearing exercise program on bone density in postmenopausal women.
G A, Caplan, J A, Ward, S R, Lord
openaire   +2 more sources

Chemoprevention in postmenopausal women

Menopause, 2008
Several large, prospective trials have evaluated tamoxifen compared with placebo for breast cancer risk reduction in women at increased risk of breast cancer. Combined results from these trials demonstrate that tamoxifen at 20 mg/d reduced the incidence of breast cancer by 38%.
openaire   +2 more sources

Sexuality in healthy postmenopausal women

Climacteric, 2003
To assess the influence of psychosocial factors, behavior and hormones on postmenopausal sexuality.Nine hundred and ninety-nine women (age range 41-60 years) underwent physical and supplementary tests and answered questionnaires regarding sexual behavior.
S R L, Penteado, A M, Fonseca, V R, Bagnoli, J S, Assis, J A, Pinotti   +4 more
openaire   +2 more sources

Androgens in postmenopausal women: a review

Menopause, 2017
Abstract There is significant interest in the use of androgen therapy for postmenopausal women. This review provides background on endogenous androgens in women, describes factors that affect circulating androgen concentrations, and examines the relationship between low levels of androgens and sexual problems.
Jan L, Shifren, Susan R, Davis
openaire   +2 more sources

Ospemifene use in postmenopausal women

Expert Opinion on Investigational Drugs, 2009
Selective estrogen receptor modulators (SERMs) are structurally different compounds that interact with intracellular estrogen receptors in target organs as estrogen agonists and antagonists. These drugs have been intensively studied over the past decades and have proven to be a highly versatile group for the treatment of different conditions associated
Gennari L., Merlotti D., Valleggi F., Nuti R.   +3 more
openaire   +3 more sources

Ovarian masses in postmenopausal women

International Journal of Gynecology & Obstetrics, 1992
AbstractIn an attempt to evaluate the significance of malignant tumors in postmenopausal women, we reviewed the charts of 380 postmenopausal women over 50 years of age, operated on in our department for adnexal masses, from January 1st 1980 to December 31st, 1989.
J, Ovadia, G A, Goldman
openaire   +2 more sources

Postmenopausal Sexuality in Thai Women*

Asia-Oceania Journal of Obstetrics and Gynaecology, 1991
AbstractWe evaluate sexuality in 100 natural menopausal women as pertains to hormones, symptoms related to intercourse, and marital relationship with sexual desire, orgasm and coital frequency. The mean age was 56.8 years while menopausal age was 50.3 years.
S, Tungphaisal, V, Chandeying, S, Sutthijumroon, O, Krisanapan, P, Udomratn   +4 more
openaire   +2 more sources

Tamoxifen in Postmenopausal Women

Drugs & Aging, 1996
Tamoxifen is a synthetic antiestrogen with both agonist and antagonist properties. It is believed to act primarily through binding to estrogen receptors in breast cancer cells, acting as a competitive inhibitor of estrogen. Tamoxifen has a wide range of systemic effects, possibly acting on every estrogen target tissue in the body.
E, Robinson, G G, Kimmick, H B, Muss
openaire   +2 more sources

Fracture prevention in postmenopausal women.

Clinical evidence, 2007
The lifetime risk of fracture in white women is 20% for the spine, 15% for the wrist, and 18% for the hip, with an exponential increase in risk beyond the age of 50 years.We conducted a systematic review and aimed to answer the following clinical question: What are the effects of treatments to prevent fractures in postmenopausal women?
Vestergaard, Peter, Mosekilde, Leif, Langdahl, Bente Lomholt   +2 more
openaire   +14 more sources

Exogenous androgens in postmenopausal women

The American Journal of Medicine, 1995
There is an increasing awareness that androgens are of therapeutic value in postmenopausal women. Evidence is emerging demonstrating the role of testosterone in both female embryologic development and normal sexual behavior and mood. Women who are androgen depleted develop physical and behavioral symptoms referred to as female androgen deficiency ...
R, Sands, J, Studd
openaire   +2 more sources